CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q421 Q122 Q222 Q322 Q422 Q123 Q223 Q323 Q423 Revenues: Clearing and transaction fees 949.3 1,138.1 1,024.6 998.6 981.4 1,200.2 1,118.3 1,085.5 1,184.5 Market data and information services 142.1 151.7 151.7 154.3 153.2 165.8 163.1 167.6 167.2 Other Revenue 55.9 56.8 60.9 74.9 73.2 75.6 78.8 84.7 87.6 Total revenues 1,147.3 1,346.6 1,237.2 1,227.8 1,207.8 1,441.6 1,360.2 1,337.8 1,439.3 Expenses: Compensation and benefits 201.7 185.2 185.3 189.6 193.0 204.5 205.7 205.5 212.9 Technology 45.8 45.9 45.9 46.8 50.0 51.3 53.3 55.6 58.5 Professional fees and outside services 32.3 31.8 32.0 35.1 38.5 38.3 37.8 32.2 36.1 Amortization of purchased intangibles 58.6 58.4 57.1 55.5 56.7 56.8 57.0 57.2 55.6 Depreciation and amortization 35.9 33.5 33.0 34.5 33.9 31.9 32.3 31.1 30.7 Licensing and other fee agreements 60.4 80.9 83.1 83.6 72.4 84.7 78.2 79.5 80.4 Other expense 80.9 51.8 51.1 43.9 95.0 60.4 57.3 56.5 101.9 Operating expenses 515.6 487.5 487.5 489.0 539.5 527.9 521.6 517.6 576.1 Operating Income 631.7 859.1 749.7 738.8 668.3 913.7 838.6 820.2 863.2 Operating Margin 55% 64% 61% 60% 55% 63% 62% 61% 60% Non-operating Income and Expense Investment income 67.8 73.1 286.9 686.2 1,152.2 1,357.7 1,568.2 1,272.5 1,076.9 Interest and other borrowing costs (41.9) (42.5) (39.9) (40.4) (39.9) (39.9) (40.2) (39.6) (39.7) Equity in net gains (losses) of unconsolidated subsidiaries 67.5 73.3 87.3 76.5 64.0 78.2 75.1 76.8 66.8 Other non-operating income (expense) 74.2 (46.7) (217.3) (581.1) (1,017.3) (1,152.8) (1,425.3) (1,155.6) (961.2) Non-operating income (expense) 167.6 57.2 117.0 141.2 159.0 243.2 177.8 154.1 142.8 Income before income taxes 799.3 916.3 866.7 880.0 827.3 1,156.9 1,016.4 974.3 1,006.0 Income taxes 174.1 205.3 204.2 200.4 189.4 273.1 238.8 224.1 191.4 Net income 625.2 711.0 662.5 679.6 637.9 883.8 777.6 750.2 814.6 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 625.2 711.0 662.5 679.6 637.9 883.8 777.6 750.2 814.6 Net Income Attributable to Common Shareholders of CME Group 613.3 702.0 654.1 671.1 629.9 872.7 767.8 740.8 804.3 Effective Tax Rate 21.8% 22.4% 23.6% 22.8% 22.8% 23.6% 23.5% 23.0% 19.0% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.71 1.96 1.82 1.87 1.76 2.43 2.14 2.06 2.24 Diluted EPS 1.71 1.95 1.82 1.87 1.75 2.43 2.14 2.06 2.24 Weighted average number of common stock shares: Basic Shares 358,582 358,609 358,641 358,715 358,885 358,933 358,940 359,020 359,197 Diluted Shares 359,019 359,180 359,205 359,288 359,190 359,313 359,429 359,619 359,693 Preferred Shares 2,890 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q421 Q122 Q222 Q322 Q422 Q123 Q223 Q323 Q423 Revenues: Clearing and transaction fees 949.3 1,138.1 1,024.6 998.6 981.4 1,200.2 1,118.3 1,085.5 1,184.5 Market data and information services 142.1 151.7 151.7 154.3 153.2 165.8 163.1 167.6 167.2 Other Revenue 55.9 56.8 60.9 74.9 73.2 75.6 78.8 84.7 87.6 Total revenues 1,147.3 1,346.6 1,237.2 1,227.8 1,207.8 1,441.6 1,360.2 1,337.8 1,439.3 Expenses: Compensation and benefits 183.7 182.8 189.5 189.1 184.6 192.8 194.4 193.5 204.4 Technology 45.6 45.8 45.9 46.8 50.0 51.3 53.3 55.6 58.5 Professional fees and outside services 27.2 30.3 31.4 35.1 38.5 38.3 37.8 32.2 36.1 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 35.6 33.5 32.9 33.8 33.9 31.9 31.8 31.1 29.8 Licensing and other fee agreements 60.4 80.9 83.1 81.9 72.4 84.7 78.2 79.5 80.4 Other expense 76.5 51.7 59.6 54.4 84.5 59.7 56.2 56.5 80.3 Operating expenses 429.0 425.0 442.4 441.1 463.9 458.7 451.7 448.4 489.5 Operating Income 718.3 921.6 794.8 786.7 743.9 982.9 908.5 889.4 949.8 Operating Margin 63% 68% 64% 64% 62% 68% 67% 66% 66% Non-operating Income and Expense Investment income 58.2 74.7 299.5 688.5 1,147.1 1,277.5 1,564.0 1,276.6 1,068.5 Interest and other borrowing costs (41.9) (42.5) (39.9) (40.4) (39.9) (39.9) (40.2) (39.6) (39.7) Equity in net gains (losses) of unconsolidated subsidiaries 78.7 84.7 98.2 89.6 76.2 91.5 88.6 90.4 85.1 Other non-operating income (expense) (33.0) (43.4) (218.5) (585.7) (1,023.3) (1,160.6) (1,429.9) (1,157.1) (958.8) Non-operating income (expense) 62.0 73.5 139.3 152.0 160.1 168.5 182.5 170.3 155.1 Income before income taxes 780.3 995.1 934.1 938.7 904.0 1,151.4 1,091.0 1,059.7 1,104.9 Income taxes 172.8 228.9 217.6 219.6 206.0 269.1 254.6 241.7 240.2 Net income 607.5 766.2 716.5 719.1 698.0 882.3 836.4 818.0 864.7 Less: net income (loss) attributable to NCI - - - - - - - - - Net Income Attributable to CME Group 607.5 766.2 716.5 719.1 698.0 882.3 836.4 818.0 864.7 Net Income Attributable to Common Shareholders of CME Group 595.7 756.6 707.5 710.0 689.1 871.1 825.9 807.9 853.8 Effective Tax Rate 22.1% 23.0% 23.3% 23.4% 22.8% 23.4% 23.3% 22.8% 21.7% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.66 2.11 1.97 1.98 1.92 2.43 2.30 2.25 2.38 Diluted EPS 1.66 2.11 1.97 1.98 1.92 2.42 2.30 2.25 2.37 Weighted average number of common stock shares: Basic Shares 358,582 358,609 358,641 358,715 358,885 358,933 358,940 359,020 359,197 Diluted Shares 359,019 359,180 359,205 359,288 359,190 359,313 359,429 359,619 359,693 Preferred Shares 2,890 4,584 4,584 4,584 4,584 4,584 4,584 4,584 4,584 -- 2 of 2 --